SynthesisFrontiers in pharmacology2025

Efficacy and safety of efruxifermin for patients with NASH/MASH: an updated systematic review and meta-analysis.

Ya-Jun Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.